Compounds for radionuclide imaging and therapy of malignant foci characterized by the increased angiogenesis
- Authors: Rakhimov M.G.1, Maruk A.Y.1, Bruskin A.B.1
- 
							Affiliations: 
							- State Scientific Center “Burnazyan Federal Medical and Biophysical Center”, Federal Medical Biological Agency of Russia
 
- Issue: Vol 65, No 2 (2016)
- Pages: 363-383
- Section: Reviews
- URL: https://journals.rcsi.science/1066-5285/article/view/237101
- DOI: https://doi.org/10.1007/s11172-016-1309-z
- ID: 237101
Cite item
Abstract
The literature data on the application and synthetic methods of compounds for imaging and therapy of malignant foci characterized by the increased angiogenesis are summarized.
About the authors
M. G. Rakhimov
State Scientific Center “Burnazyan Federal Medical and Biophysical Center”, Federal Medical Biological Agency of Russia
														Email: amaruk@list.ru
				                					                																			                												                	Russian Federation, 							46 ul. Zhivopisnaya, Moscow, 123182						
A. Ya. Maruk
State Scientific Center “Burnazyan Federal Medical and Biophysical Center”, Federal Medical Biological Agency of Russia
							Author for correspondence.
							Email: amaruk@list.ru
				                					                																			                												                	Russian Federation, 							46 ul. Zhivopisnaya, Moscow, 123182						
A. B. Bruskin
State Scientific Center “Burnazyan Federal Medical and Biophysical Center”, Federal Medical Biological Agency of Russia
														Email: amaruk@list.ru
				                					                																			                												                	Russian Federation, 							46 ul. Zhivopisnaya, Moscow, 123182						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					